A recent meta-study found that increased tumor infiltration with Th1 and CD8+ T cells was associated with the expression status of STAT2 and its target CXCL10, suggesting that the activation of this pathway could predict the outcome in oral cancer patients [47]. The gene discussed is CXCL10; the disease is neoplasm.